Inactivations of p16(INK4a)-α, p16(INK4a)-β and p15(INK4b) genes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced murine lymphomas

Oncogene

Volumn 16, Issue 6, 1998, Pages 803-808

  Zhuang, Shi Mei ^a   Schippert, Åsa ^a   Haugen Strano, Astrid ^b   Wiseman, Roger W ^b   Söderkvist, Peter ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

1,3 butadiene; 2',3' dideoxycytidine; Murine lymphomas; p15(INK4b); p16(INK4a) ; p16(INK4a)

Indexed keywords

1,3 BUTADIENE; CYCLIN DEPENDENT KINASE INHIBITOR; DNA; PROTEIN P16; PROTEIN P53; ZALCITABINE; 1,3 BUTADIENE DERIVATIVE; 1,3-BUTADIENE; CARCINOGEN; CARRIER PROTEIN; CDKN2B PROTEIN, MOUSE; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2B; PROTEIN P16INK4A; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA METHYLATION; EXON; FEMALE; GENE DELETION; GENE LOCUS; GENE REARRANGEMENT; GENE REPRESSION; LYMPHOMA; MALE; MOUSE; NONHUMAN; ONCOGENE RAS; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; SOUTHERN BLOTTING; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; CPG ISLAND; DNA SEQUENCE; EXPERIMENTAL NEOPLASM; GENETICS; HOMOZYGOTE; METHODOLOGY; SINGLE STRAND CONFORMATION POLYMORPHISM;

ANIMALIA; MURINAE;

ANIMALS; BUTADIENES; CARCINOGENS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CPG ISLANDS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA, NEOPLASM; HOMOZYGOTE; LYMPHOMA; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; POINT MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS (GENETICS); SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEINS; ZALCITABINE;

EID: 0032509862     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201600     Document Type: Article

References (52)

1. Angel JM, Morizot DC and Richie ER. (1989). J. Natl. Cancer Inst., 81, 1652 - 1655.
2. Arap W, Knudsen ES, Wang JYJ, Cavenee WK and Su Huang H-J. (1997). Oncogene, 14, 603 - 609.
3. Batova A, Diccianni MB, Yu JC, Nobori T, Link MP, Pullen J and Yu AL. (1997). Cancer Res., 57, 832 - 836.
4. Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, Mao L, Herath J, Jenkins R, Westra W, Rutter JL, Buckler A, Gabrielson E, Tockman M, Cho KR, Hedrick L, Bova GS, Isaacs W, Koch W, Schwab D and Sidransky D. (1995). Nature Genet., 11, 210 - 212.
5. Divine BJ. (1990). Environ. Health Perspect., 86, 119 - 128.
6. Drinkwater NR and Bennett LM. (1991). Prog. Exp. Tumor Res., 33, 1 - 20.
7. Flores JF, Walker GJ, Glendening JM, Haluska FG, Castresana JS, Rubio M-P, Pastorfide GC, Boyer LA, Kao WH, Bulyk ML, Barnhill RL, Hayward NK, Housman DE and Fountain JW. (1996). Cancer Res., 56, 5023 - 5032.
8. Fueyo J, Gomez-manzano C, Bruner JM, Saito Y, Zhang B, Zhang W, Levin VA, Yung WKA and Kyritsis AP. (1996). Oncogene, 13, 1615 - 1619.
9. Goldstein AM, Fraser MC, Struewing JP, Hussussian CJ, Ranade K, Zametkin DP, Fontaine LS, Organic SM, Dracopoli NC, Clarke Jr, WH and Tucker MA. (1995). N. Engl. J. Med., 333, 970 - 974.
10. Hannon GJ and Beach D. (1994). Nature, 371, 257 - 261.
11. Harris G and Lawley PD. (1994). Carcinogenesis, 15, 1211 -1217.
12. Herman JG, Jen J, Merlo A and Baylin SB. (1996). Cancer Res., 56, 722 - 727.
13. Herman JG, Civin CI, Issa J-PJ, Collector MI, Sharkis SJ and Baylin SB. (1997). Cancer Res., 57, 837 - 841.
14. Herzog CR, Wiseman RW and You M. (1994). Cancer Res., 54, 4007 - 4010.
15. Herzog CR, Soloff EV, McDoniels AL, Tyson FL, Malkinson AM, Haugen-Strano A, Wiseman RW, Anderson MW and You M. (1996). Oncogene, 13, 1885 -1891.
16. Heyman M, Rasool O, Borgonovo Brandter L, Liu Y, Grandér D, Einhorn S and Söderhäll S. (1996). Blood, 87, 1657 - 1658.
17. Hirama T and Koeffler HP. (1995). Blood, 86, 841 - 854.
18. Hooper WC. (1991). Leuk. Res., 15, 179 - 184.
19. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PAT, Ally DS, Sheahan MD, Clark WH Jr, Tucker MA and Dracopoli NC. (1994). Nature Genet., 8, 15 - 21.
20. IARC. (1992). IARC Monographs, 54, 237 - 285.
21. Ishizaka ST and Lilly F. (1989). Cancer Res., 49, 1214 - 1219.
22. Jen J, Harper JW, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, Willson JKV, Kinzler KW and Vogelstein B. (1994). Cancer Res., 54, 6353 - 6358.
23. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshmam K, Tavtigian SV, Stockert E, Day RS III, Johnson BE and Skolnick MH. (1994). Science, 264, 436 - 440.
24. Koh J, Enders GH, Dynlacht BD and Harlow Ed. (1995). Nature, 375, 506 - 510.
25. Liggett Jr, WH, Sewell DA, Rocco J, Ahrendt SA, Koch W and Sidransky D. (1996). Cancer Res., 56, 4119 - 4123.
26. Linardopoulos S, Street AJ, Quelle DE, Parry D, Peters G, Sherr CJ, and Balmain A. (1995). Cancer Res., 55, 5168 -5172.
27. Lilischkis R, Sarcevic B, Kennedy C, Warlters A and Sutherland RL. (1996). Int. J. Cancer, 66, 249 - 254.
28. Lois AF, Cooper LT, Geng Y, Nobori T and Carson D. (1995). Cancer Res., 55, 4010 - 4013.
29. Lukas J, Parry D, Aagaard L, Mann DJ, Bartkova J, Strauss M, Peters G and Barlek J. (1995). Nature, 375, 503 - 506.
30. Malumbres M, Pérez de Castro I, Santos J, Meléndez B, Mangues R, Serrano M, Pellicer A and Fernandez-Piqueras J. (1997). Oncogene, 14, 1361 - 1370.
31. Mao L, Merlo A, Bedi G, Shapiro GI, Edwards CD, Rollins BJ and Sidransky D. (1995). Cancer Res., 55, 2995 - 2997.
32. Matanoski GM, Santos-Burgoa C and Schwartz L. (1990). Environ. Health Perspect., 86, 107 - 117.
33. Medema RH, Herrera RE, Lam F and Weinberg RA. (1995). Proc. Natl. Acad. Sci. USA, 92, 6289 - 6293.
34. Melnick RL, Huff J, Chou BJ and Miller RA. (1990). Cancer Res., 50, 6592 - 6599.
35. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB and Sidransky D. (1995). Nature Med., 1, 686 - 692.
36. Newcomb EW, Steinberg JJ and Pellicer A. (1988). Cancer Res., 48, 5514 - 5521.
37. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K and Carson DA. (1994). Nature, 368, 753 - 756.
38. Okamoto A, Demetrick DJ, Spillare EA, Hagiwara K, Hussain SP, Bennett WP, Forrester K, Gerwin B, Serrano M, Beach DH and Harris CC. (1994). Proc. Natl. Acad. Sci. USA, 91, 11045 - 11049.
39. Quelle DE, Zindy F, Ashmun RA and Sherr CJ. (1995a). Cell, 83, 993 - 1000.
40. Quelle DE, Ashmun RA, Hannon GJ, Rehberger PA, Trono D, Richter KH, Walker C, Beach D, Sherr CJ and Serrano M. (1995b). Oncogene, 11, 635 - 645.
41. Rao GN, Collins BJ, Giles HD, Heath JE, Foley JF, May RD and Buckley LA. (1996). Cancer Res., 56, 4666 - 4672.
42. Rasool O, Heyman M, Borgonovo Brandter L, Liu Y, Grandér D, Söderhäll S and Einhorn S. (1995). Blood, 85, 3431 - 3436.
43. Sado T, Kamisaku H and Kubo E. (1985). J. Immunol., 134, 704 - 710.
44. Serrano M, Hannon GJ and Beach D. (1993). Nature, 366, 704 - 707.
45. Serrano M, Lee H-W, Chin L, Cordon-Cardo C, Beach D and Depinho RA. (1996). Cell, 85, 27 - 37.
46. Siebert R, Willers CP, Schramm A, Fosså A, Gana Dresen IM, Uppenkamp M, Nowrousian MR, Seeber S and Opalka B. (1995). Brit. J. Haematol., 91, 350 - 354.
47. Starnes MC and Cheng YC. (1987). J. Biol. Chem., 262, 988 - 991.
48. Stone S, Jiang P, Dayananth P, Tavtigian SV, Katcher H, Parry D, Peters G and Kamb A. (1995). Cancer Res., 55, 2988 - 2994.
49. Whelan AJ, Bartsch D and Goodfellow PJ. (1995). N. Engl. J. Med., 333, 975 - 977.
50. Yang R, Combart AF, Serrano M and Koeffler HP. (1995). Cancer Res., 55, 2503 - 2506.
51. Zhuang S-M, Eklund LK, Cochran C, Rao GN, Wiseman RW and Söderkvist P. (1996). Cancer Res., 56, 3338 - 3343.
52. Zhuang S-M, Cochran C, Goodrow T, Wiseman RW and Söderkvist P. (1997). Cancer Res., 57, 2710 - 2714.